<?xml version="1.0" encoding="ISO-8859-1"?>

<?xml-stylesheet type="text/css" href="https://www.webwire.com/includes/rssstyle.css"?>

<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
  
  <!-- Issuers of news/press releases and NOT WebWire are solely responsible for the accuracy of the content. -->



    <title>WebWire | News by Industry : Infectious Disease Control</title>
    <link>https://www.webwire.com/</link>
    <description>Infectious Disease Control News by WebWire</description>
    <language>en-US</language>
    <copyright>Copyright &#169; 2026 WebWire. All Rights Reserved.</copyright>
    <ttl>15</ttl>
    <lastBuildDate>Thu, 10 Sep 2026 14:39:03 EDT</lastBuildDate>
	<image>
      <title>WebWire | News by Industry : Infectious Disease Control</title>
      <width>140</width>
      <height>32</height>
      <link>https://www.webwire.com/</link>
      <url>https://www.webwire.com/imgs/webwire_logo_140x32.gif</url>
    </image>
	

  <item>
     <title>Telehealth and Medicine Today Accepted for Inclusion in DOAJ</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=360182</link>
     <pubDate>Wed, 9 Sep 2026 08:00:00 EDT</pubDate>
     <description><![CDATA[<p> Partners in Digital Health today announced that  Telehealth and Medicine Today  (THMT) has been accepted for inclusion in the Directory of Open Access Journals (DOAJ), a globally recognized directory of peer reviewed, open access scholarly journals. -   -  The milestone increases the visibility and discoverability of THMT among researchers, clinicians, healthcare leaders, librarians, institutions and discovery services worldwide. Inclusion follows an extensive review of the journal&#39;s open acce...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=360182">https://www.webwire.com/ViewPressRel.asp?aId=360182</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/54628/360182/360182-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID360182</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>As U.S. Measles Cases Rise and Biological Threats Remain Under Surveillance, Ashish Jha to Headline ConV2X New York</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=359479</link>
     <pubDate>Mon, 31 Aug 2026 08:00:00 EDT</pubDate>
     <description><![CDATA[<p>Against a backdrop of rising U.S. measles cases and continued surveillance of H5 bird flu,  Ashish K. Jha, MD, MPH, former White House COVID-19 Response Coordinator and Co-Founder and CEO of BioRadar, will headline the  ConV2X Smart Tech Transformation in Healthcare &amp; Life Sciences Executive Summit, taking place October 29&#8211;30, 2026, at the Historic GE Building, ILR Conference Center, in New York City. -   -  Jha will deliver the opening keynote, &#8220;Misdiagnosed: The Real Drivers</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=359479">https://www.webwire.com/ViewPressRel.asp?aId=359479</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/54628/359479/359479-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID359479</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>ConV2X Expands Cambridge Executive Summit With New Healthcare, FDA, AI, and Cybersecurity Leaders</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=359477</link>
     <pubDate>Wed, 26 Aug 2026 08:00:00 EDT</pubDate>
     <description><![CDATA[<p> ConV2X today announced a new group of in-person speakers joining its September 24&#8211;25 executive summit at The Foundry in Cambridge, Massachusetts, expanding the multidisciplinary dialogue around AI infrastructure, decentralized health, cybersecurity, regulation, clinical implementation and the technologies reshaping healthcare and life sciences. -   -  The newly announced in-person participants bring experience from healthcare delivery, FDA leadership and regulation, enterprise AI, cybersecurit...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=359477">https://www.webwire.com/ViewPressRel.asp?aId=359477</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/54628/359477/359477-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID359477</guid>
     <dc:type>Article</dc:type>
  </item>

  </channel>
</rss>
